In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular FDA's Overreach on Compounded Peptides The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype